Juan Ramón Lacalle

Suggest Changes
Learn More
BACKGROUND Efavirenz and lopinavir/ritonavir are both recommended antiretroviral agents for combination first-line therapy, although information on direct comparisons between them is scarce. A(More)
  • 1